---
$id: https://graph.org.ai/products/commodity/51112511
$type: Product
source: UNSPSC
code: "51112511"
title: "Mafosfamide"
class: "51112500"
classTitle: "Alkylating agent nitrogen mustard compounds"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Mafosfamide

**UNSPSC Code**: 51112511
**Class**: [Alkylating agent nitrogen mustard compounds](Alkylating agent nitrogen mustard compounds.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nitrogen mustard compound with the molecular formula C9H19Cl2N2O5PS2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5970HH9923, chemically known as ethanesulfonic acid, 2-(((2r,4r)-2-(bis(2-chloroethyl)amino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl)thio)-, rel- but more generally known as mafosfamide, which bears US NIH Compound Identifier 104746. European Medicines Agency schedules Mafosfamide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08635MIG. The term MAFOSFAMIDE is an International Non-Proprietary Name. MAFOSFAMIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule mafosfamide under HS 29349990 and SITC 51579. As of Q4 2014, MAFOSFAMIDE remains US FDA's Preferred Term for this commodity. Mafosfamide bears US NLM identifiers UMLS ID C0065506 and NCI Concept Code C1150. SMILES: CLCCN(P1(=O)OCCC(SCCS(=O)(=O)O)N1)CCCL.

